Form 4 for TTRX Turn Therapeutics Inc.
Accepted 2026-04-03 08:09:33 ET · period of report 2026-04-02 · accession 0001213900-26-039715 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-04-03 08:09 | 2026-04-02 | TTRX | Burnam Bradley Evan | CEO, Dir, 10% | G - Gift | $0.00 | -300.0K | 15.72M | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-02 | G | D | 300,000 | $0.00 | 15,716,260 | I By BEB Holdings, LLC | — | — | (F1) Represents shares of common stock held by BEB Holdings, LLC. The reporting person is the sole member of BEB Holdings, LLC and has sole voting and dispositive power with regard to the shares held by BEB Holdings, LLC. Accordingly, all shares held by BEB Holdings, LLC may be deemed to be beneficially owned by the reporting person. |